Tanarra Ventures

Tanarra Ventures is the growth-equity arm of a Melbourne-headquartered alternative asset manager, deploying highly structured capital into revenue-generating technology platforms that have moved past product-market fit and need fuel for scale. Within healthcare, the firm leans toward health IT and digital health businesses where software defines the unit economics. The broader Tanarra group operates across credit, equities, and private markets, and the venture practice inherits that institutional diligence posture rather than the looser pattern-matching of seed-stage firms. Limited public information is available regarding specific portfolio companies and named investing partners on the venture team, so founders should confirm sector coverage directly.

Checks run from roughly 5 million to 25 million dollars at Series B, Series C, and later growth rounds, putting Tanarra in the band where governance terms, board seats, and structured downside protection become standard. Geography is centered on Australia with a Melbourne base, and the firm’s institutional footprint suggests comfort with cross-border deals where Australian companies expand internationally.

Founders engaging Tanarra should expect a process that resembles private equity diligence more than early-stage venture: detailed financial modeling, customer reference work, and considered structuring of preferences and protective provisions. The trade-off is meaningful capital with patient holding periods and access to a broader alternative-asset platform. Companies still pre-revenue or experimenting with their wedge are not the fit. The right candidates are scaling SaaS and digital health operators with clean metrics, ARR momentum, and a clear path to profitability or a strategic exit. Initial conversations should clarify check structure, board composition expectations, and any preference stacking that would affect future rounds.